Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
114.42
+2.82 (2.53%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $14.15 billion as of October 11, 2024. Its market cap has increased by 200.43% in one year.
Market Cap
14.15B
Enterprise Value
12.73B
1-Year Change
200.43%
Ranking
Category
Stock Price
$114.42
Market Cap Chart
Since June 12, 2020, Vaxcyte's market cap has increased from $1.22B to $14.15B, an increase of 1,057.55%. That is a compound annual growth rate of 75.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 12.77B | 113.71% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.57% |
| Dec 31, 2021 | 1.26B | -7.23% |
| Dec 31, 2020 | 1.35B | 10.71% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revvity | 14.99B |
| Genmab | 14.95B |
| Tenet Healthcare | 14.93B |
| Summit Therapeutics | 14.87B |
| Universal Health Services | 14.30B |
| Viatris | 13.58B |
| DaVita | 13.50B |
| BioMarin Pharmaceutical | 13.39B |